Showing results (1-10 of 334) with videos related to
Sort By:
Pageof 34
Diabetes Research and Clinical Practice|February 10, 2020
Treatment paradigm shifting implications of recent cardiovascular outcome trials: Core insights on the brink of the 2020iesEberhard Standl, Oliver SchnellEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Impaired glucose tolerance, diabetes, and cardiovascular diseaseOliver Schnell, Eberhard StandlDiabetes Research and Clinical Practice|April 8, 2021
Heart failure outcomes and Covid-19Eberhard Standl, Oliver SchnellCells|April 25, 2025
Increased Risk of Cancer-An Integral Component of the Cardio-Renal-Metabolic Disease Cluster and Its ManagementEberhard Standl, Oliver SchnellDiabetes & Vascular Disease Research|April 18, 2012
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluationEberhard Standl, Oliver SchnellBest Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
The impact of glucose-lowering therapy on cardiovascular outcomesEberhard Standl, Martin Müller, Oliver SchnellCardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver SchnellHerz|September 2, 2004
[Inflammation and atherogenesis in diabetes mellitus - new therapeutic approaches]Wolfgang Otter, Eberhard Standl, Oliver SchnellDiabetes/Metabolism Research and Reviews|January 3, 2013
What should be the antihypertensive drug of choice in diabetic patients and should we avoid drugs that increase glucose levels? Pro and ConsEberhard Standl, Michael Erbach, Oliver SchnellDiabetes Care|April 29, 2011
Postprandial hyperglycemia and glycemic variability: should we care?Eberhard Standl, Oliver Schnell, Antonio CerielloPageof 34